A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

GSK (GSK) stock is in focus as an expert panel of the European Medicines Agency ((EMA)) endorses the company's Arexvy RSV ...

The vaccines were found to decrease the risk of needing medical care in the first six months after vaccination by 76 percent ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) ...

Purpose: Viral infections elicit different forms of host cell death. Indeed, pathways of programmed cell death (PCD) have emerged as central events in the pathogenesis of various viruses. Regulating ...

A systematic review of 511 studies showed that immunization against COVID-19, RSV, and influenza was safe and effective in people of all ages. The researchers reviewed the latest evidence since the ...